Newstral
Zosano Pharma
- Migraine patch developer Zosano Pharma suspends program, cutting more jobsbizjournals.com
- Migraine patch Zosano Pharma developer suspends program, cutting more jobsbizjournals.com
- LGlobal Alternative Drug Delivery Systems Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | Top Brands: Lab International, Hospira, Aveva Drug Delivery, SRI international, A…liverpoolstudentmedia.com
- FDA trips up Zosano Pharma's migraine patch 3 weeks before approval datebizjournals.com
- East Bay life sciences firm hopes to break Bay Area IPO lull with $68.4M offeringbizjournals.com
- Carbylan Therapeutics lines up $4M debt financing after putting off $93M IPObizjournals.com
- CBiz Break: S.F. genetic-testing firm Invitae passes IPO test, gains in debutcontracostatimes.com
- Genetic testing firm Invitae tops IPO targets, raises $102Mbizjournals.com
- 2 more Bay Area life science IPOs coming this week, Invitae sets terms for next weekbizjournals.com
- After big Box debut, next 4 Bay Area IPOs are all in life sciencesbizjournals.com
- Medical device maker Avinger ups IPO target by 7%bizjournals.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.